Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 123 entries
Sorted by: Best Match Show Resources per page
Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels.

Mediterranean journal of hematology and infectious diseases

Al Huneini M, Alkindi S, Panjwani V, Al Falahi K, Al Balushi B, Gravell D, Ho CH, Krishnamoorthy R, Pathare AV.
PMID: 28512557
Mediterr J Hematol Infect Dis. 2017 Apr 20;9(1):e2017028. doi: 10.4084/MJHID.2017.028. eCollection 2017.

OBJECTIVES: To explore the incidence of vaso-occlusive crisis (VOC) in Blood Group "O" sickle cell disease (SCD) patients, and correlate it with the blood group and thrombospondin (TSP) levels.METHODS: In 89 consecutive SCD patients, blood samples were obtained for...

Cite
Al Huneini M, Alkindi S, Panjwani V, et al. Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels. Mediterr J Hematol Infect Dis. 2017;9(1):e2017028doi: 10.4084/MJHID.2017.028.
Al Huneini, M., Alkindi, S., Panjwani, V., Al Falahi, K., Al Balushi, B., Gravell, D., Ho, C. H., Krishnamoorthy, R., & Pathare, A. V. (2017). Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels. Mediterranean journal of hematology and infectious diseases, 9(1), e2017028. https://doi.org/10.4084/MJHID.2017.028
Al Huneini, M, et al. "Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels." Mediterranean journal of hematology and infectious diseases vol. 9,1 (2017): e2017028. doi: https://doi.org/10.4084/MJHID.2017.028
Al Huneini M, Alkindi S, Panjwani V, Al Falahi K, Al Balushi B, Gravell D, Ho CH, Krishnamoorthy R, Pathare AV. Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels. Mediterr J Hematol Infect Dis. 2017 Apr 20;9(1):e2017028. doi: 10.4084/MJHID.2017.028. eCollection 2017. PMID: 28512557; PMCID: PMC5419181.
Copy Download .nbib Format: NLM
Acquired von Willebrand Disease in Patients with Chronic Myeloproliferative Disorders.

Leukemia & lymphoma

Tatewaki W, Shibata A.
PMID: 27456408
Leuk Lymphoma. 1989;1(1):51-7. doi: 10.3109/10428198909042459.

In chronic myeloproliferative disorders(CMPD), thrombohaemorrhagic complications are relatively common, in association with thromocytosis. We studied the multimeric composition of plasma von Willebrand factor(vWf) in CMPD and investigated the possibilities of in vivo or in vitro proteolysis. The relative amount...

Cite
Tatewaki W, Shibata A. Acquired von Willebrand Disease in Patients with Chronic Myeloproliferative Disorders. Leuk Lymphoma. 1989;1(1):51-7doi: 10.3109/10428198909042459.
Tatewaki, W., & Shibata, A. (1989). Acquired von Willebrand Disease in Patients with Chronic Myeloproliferative Disorders. Leukemia & lymphoma, 1(1), 51-7. https://doi.org/10.3109/10428198909042459
Tatewaki, W, and Shibata, A. "Acquired von Willebrand Disease in Patients with Chronic Myeloproliferative Disorders." Leukemia & lymphoma vol. 1,1 (1989): 51-7. doi: https://doi.org/10.3109/10428198909042459
Tatewaki W, Shibata A. Acquired von Willebrand Disease in Patients with Chronic Myeloproliferative Disorders. Leuk Lymphoma. 1989;1(1):51-7. doi: 10.3109/10428198909042459. PMID: 27456408.
Copy Download .nbib Format: NLM
Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding.

Experimental hematology & oncology

Cugno M, Tedeschi A, Siboni SM, Stufano F, Depetri F, Franchi F, Griffini S, Peyvandi F.
PMID: 24926417
Exp Hematol Oncol. 2014 Jun 04;3:15. doi: 10.1186/2162-3619-3-15. eCollection 2014.

A 91-year-old woman affected with acquired Von Willebrand (VW) syndrome and intestinal angiodysplasias presented with severe gastrointestinal bleeding (hemoglobin 5 g/dl). Despite replacement therapy with VW factor/factor VIII concentrate qid, bleeding did not stop (eleven packed red blood cell...

Cite
Cugno M, Tedeschi A, Siboni SM, et al. Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding. Exp Hematol Oncol. 2014;3:15doi: 10.1186/2162-3619-3-15.
Cugno, M., Tedeschi, A., Siboni, S. M., Stufano, F., Depetri, F., Franchi, F., Griffini, S., & Peyvandi, F. (2014). Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding. Experimental hematology & oncology, 315. https://doi.org/10.1186/2162-3619-3-15
Cugno, Massimo, et al. "Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding." Experimental hematology & oncology vol. 3 (2014): 15. doi: https://doi.org/10.1186/2162-3619-3-15
Cugno M, Tedeschi A, Siboni SM, Stufano F, Depetri F, Franchi F, Griffini S, Peyvandi F. Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding. Exp Hematol Oncol. 2014 Jun 04;3:15. doi: 10.1186/2162-3619-3-15. eCollection 2014. PMID: 24926417; PMCID: PMC4055248.
Copy Download .nbib Format: NLM
Aggregation Fails to Increase Cytosolic [Ca(2+)] in Aequorin-loaded Human Platelets.

Platelets

Orchard MA, Scrutton MC.
PMID: 21043842
Platelets. 1993;4(4):201-6. doi: 10.3109/09537109309013218.

Studies were performed to determine whether formation of platelet aggregates itself, could cause an increase in cytosolic [Ca(2+)]([Ca(2+)](i)) which is independent of that resulting from the addition of agonists which induce aggregation. An increase in [Ca(2+)](i) did not coincide...

Cite
Orchard MA, Scrutton MC. Aggregation Fails to Increase Cytosolic [Ca(2+)] in Aequorin-loaded Human Platelets. Platelets. 1993;4(4):201-6doi: 10.3109/09537109309013218.
Orchard, M. A., & Scrutton, M. C. (1993). Aggregation Fails to Increase Cytosolic [Ca(2+)] in Aequorin-loaded Human Platelets. Platelets, 4(4), 201-6. https://doi.org/10.3109/09537109309013218
Orchard, M A, and Scrutton, M C. "Aggregation Fails to Increase Cytosolic [Ca(2+)] in Aequorin-loaded Human Platelets." Platelets vol. 4,4 (1993): 201-6. doi: https://doi.org/10.3109/09537109309013218
Orchard MA, Scrutton MC. Aggregation Fails to Increase Cytosolic [Ca(2+)] in Aequorin-loaded Human Platelets. Platelets. 1993;4(4):201-6. doi: 10.3109/09537109309013218. PMID: 21043842.
Copy Download .nbib Format: NLM
[Mild haemophilia A in Iceland.].

Laeknabladid

Jensson O, Jonsdottir S.
PMID: 20065483
Laeknabladid. 1995 Jun;81(6):477-83.

A family survey of mild hemophilia A has been carried out during the last 25 years. Presently these families contain 27 living affected males or approximately twice the number of males with severe form of hemophilia A in Iceland....

Cite
Jensson O, Jonsdottir S. [Mild haemophilia A in Iceland.]. Laeknabladid. 1995;81(6):477-83
Jensson, O., & Jonsdottir, S. (1995). [Mild haemophilia A in Iceland.]. Laeknabladid, 81(6), 477-83.
Jensson, O, and Jonsdottir, S. "[Mild haemophilia A in Iceland.]." Laeknabladid vol. 81,6 (1995): 477-83.
Jensson O, Jonsdottir S. [Mild haemophilia A in Iceland.]. Laeknabladid. 1995 Jun;81(6):477-83. Icelandic. PMID: 20065483.
Copy Download .nbib Format: NLM
The role of platelets in the coagulopathy of heatstroke- a study of platelet aggregation in heatstroke patients during the Makkah pilgrimage (Haj) to Makkah.

Platelets

Al-Mashhadani SA, Gader AM, Al Harthi S.
PMID: 16793631
Platelets. 1997 Jan;8(1):37-42. doi: 10.1080/09537109777528.

Platelet aggregation was undertaken in platelet rich plasma in 34 heat-stroke patients during the Muslim pilgrimage (Haj) to Makkah; 18 were males and 16 were females; their ages ranged from 36 to 80 years (mean SD = 58 10)....

Cite
Al-Mashhadani SA, Gader AM, Al Harthi S. The role of platelets in the coagulopathy of heatstroke- a study of platelet aggregation in heatstroke patients during the Makkah pilgrimage (Haj) to Makkah. Platelets. 1997;8(1):37-42doi: 10.1080/09537109777528.
Al-Mashhadani, S. A., Gader, A. M., & Al Harthi, S. (1997). The role of platelets in the coagulopathy of heatstroke- a study of platelet aggregation in heatstroke patients during the Makkah pilgrimage (Haj) to Makkah. Platelets, 8(1), 37-42. https://doi.org/10.1080/09537109777528
Al-Mashhadani, S A, et al. "The role of platelets in the coagulopathy of heatstroke- a study of platelet aggregation in heatstroke patients during the Makkah pilgrimage (Haj) to Makkah." Platelets vol. 8,1 (1997): 37-42. doi: https://doi.org/10.1080/09537109777528
Al-Mashhadani SA, Gader AM, Al Harthi S. The role of platelets in the coagulopathy of heatstroke- a study of platelet aggregation in heatstroke patients during the Makkah pilgrimage (Haj) to Makkah. Platelets. 1997 Jan;8(1):37-42. doi: 10.1080/09537109777528. PMID: 16793631.
Copy Download .nbib Format: NLM
Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repair.

HSR proceedings in intensive care & cardiovascular anesthesia

Pappalardo F, Della Valle P, Maj G, Franco A, Lattuada A, Landoni G, Zangrillo A, D'Angelo A.
PMID: 23440905
HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(2):119-27.

INTRODUCTION: No data exist on the prevalence of primary hemostatic defects and acquired von Willebrand disease in mitral valve prolapse with severe regurgitation.METHODS: Primary hemostasis was evaluated by PFA-100, von Willebrand Factor Antigen (vWF:Ag) and Ristocetin cofactor (vWF:RiCof) assays...

Cite
Pappalardo F, Della Valle P, Maj G, et al. Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repair. HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(2):119-27
Pappalardo, F., Della Valle, P., Maj, G., Franco, A., Lattuada, A., Landoni, G., Zangrillo, A., & D'Angelo, A. (2010). Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repair. HSR proceedings in intensive care & cardiovascular anesthesia, 2(2), 119-27.
Pappalardo, F, et al. "Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repair." HSR proceedings in intensive care & cardiovascular anesthesia vol. 2,2 (2010): 119-27.
Pappalardo F, Della Valle P, Maj G, Franco A, Lattuada A, Landoni G, Zangrillo A, D'Angelo A. Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repair. HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(2):119-27. PMID: 23440905; PMCID: PMC3484616.
Copy Download .nbib Format: NLM
Effect of statins on platelet function in patients with hyperlipidemia.

Archives of medical science : AMS

Sikora J, Kostka B, Marczyk I, Krajewska U, Chałubiński M, Broncel M.
PMID: 24049520
Arch Med Sci. 2013 Aug 30;9(4):622-8. doi: 10.5114/aoms.2013.36905. Epub 2013 Aug 08.

INTRODUCTION: It is generally assumed that cholesterol reduction by statins is the predominant therapeutic result underlying their beneficial effects in cardiovascular disease. However, the action of statins may be partially independent of their effects on plasma cholesterol levels, as...

Cite
Sikora J, Kostka B, Marczyk I, et al. Effect of statins on platelet function in patients with hyperlipidemia. Arch Med Sci. 2013;9(4):622-8doi: 10.5114/aoms.2013.36905.
Sikora, J., Kostka, B., Marczyk, I., Krajewska, U., Chałubiński, M., & Broncel, M. (2013). Effect of statins on platelet function in patients with hyperlipidemia. Archives of medical science : AMS, 9(4), 622-8. https://doi.org/10.5114/aoms.2013.36905
Sikora, Joanna, et al. "Effect of statins on platelet function in patients with hyperlipidemia." Archives of medical science : AMS vol. 9,4 (2013): 622-8. doi: https://doi.org/10.5114/aoms.2013.36905
Sikora J, Kostka B, Marczyk I, Krajewska U, Chałubiński M, Broncel M. Effect of statins on platelet function in patients with hyperlipidemia. Arch Med Sci. 2013 Aug 30;9(4):622-8. doi: 10.5114/aoms.2013.36905. Epub 2013 Aug 08. PMID: 24049520; PMCID: PMC3776183.
Copy Download .nbib Format: NLM
Low flow rate alters haemostatic parameters in an ex-vivo extracorporeal membrane oxygenation circuit.

Intensive care medicine experimental

Ki KK, Passmore MR, Chan CHH, Malfertheiner MV, Fanning JP, Bouquet M, Millar JE, Fraser JF, Suen JY.
PMID: 31432279
Intensive Care Med Exp. 2019 Aug 20;7(1):51. doi: 10.1186/s40635-019-0264-z.

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is a life-saving modality used to manage cardiopulmonary failure refractory to conventional medical and surgical therapies. Despite advances in ECMO equipment, bleeding and thrombosis remain significant complications. While the flow rate for ECMO support...

Cite
Ki KK, Passmore MR, Chan CHH, et al. Low flow rate alters haemostatic parameters in an ex-vivo extracorporeal membrane oxygenation circuit. Intensive Care Med Exp. 2019;7(1):51doi: 10.1186/s40635-019-0264-z.
Ki, K. K., Passmore, M. R., Chan, C. H. H., Malfertheiner, M. V., Fanning, J. P., Bouquet, M., Millar, J. E., Fraser, J. F., & Suen, J. Y. (2019). Low flow rate alters haemostatic parameters in an ex-vivo extracorporeal membrane oxygenation circuit. Intensive care medicine experimental, 7(1), 51. https://doi.org/10.1186/s40635-019-0264-z
Ki, Katrina K, et al. "Low flow rate alters haemostatic parameters in an ex-vivo extracorporeal membrane oxygenation circuit." Intensive care medicine experimental vol. 7,1 (2019): 51. doi: https://doi.org/10.1186/s40635-019-0264-z
Ki KK, Passmore MR, Chan CHH, Malfertheiner MV, Fanning JP, Bouquet M, Millar JE, Fraser JF, Suen JY. Low flow rate alters haemostatic parameters in an ex-vivo extracorporeal membrane oxygenation circuit. Intensive Care Med Exp. 2019 Aug 20;7(1):51. doi: 10.1186/s40635-019-0264-z. PMID: 31432279; PMCID: PMC6702240.
Copy Download .nbib Format: NLM
Acquired von Willebrand Disease Associated with Mantle Cell Lymphoma.

Case reports in hematology

Maas D, Laros-van Gorkom B, Gianotten S, Cruijsen M, van Heerde W, Nijziel M.
PMID: 29651351
Case Rep Hematol. 2018 Jan 30;2018:7973297. doi: 10.1155/2018/7973297. eCollection 2018.

We present a rare case of acquired von Willebrand syndrome (AVWS) caused by a mantle cell lymphoma. A 61-year-old male suffered from recurrent bleeding symptoms since a few months. Initially, physical examination was normal. von Willebrand factor antigen (VWF:Ag)...

Cite
Maas D, Laros-van Gorkom B, Gianotten S, et al. Acquired von Willebrand Disease Associated with Mantle Cell Lymphoma. Case Rep Hematol. 2018;2018:7973297doi: 10.1155/2018/7973297.
Maas, D., Laros-van Gorkom, B., Gianotten, S., Cruijsen, M., van Heerde, W., & Nijziel, M. (2018). Acquired von Willebrand Disease Associated with Mantle Cell Lymphoma. Case reports in hematology, 20187973297. https://doi.org/10.1155/2018/7973297
Maas, Dominique, et al. "Acquired von Willebrand Disease Associated with Mantle Cell Lymphoma." Case reports in hematology vol. 2018 (2018): 7973297. doi: https://doi.org/10.1155/2018/7973297
Maas D, Laros-van Gorkom B, Gianotten S, Cruijsen M, van Heerde W, Nijziel M. Acquired von Willebrand Disease Associated with Mantle Cell Lymphoma. Case Rep Hematol. 2018 Jan 30;2018:7973297. doi: 10.1155/2018/7973297. eCollection 2018. PMID: 29651351; PMCID: PMC5830951.
Copy Download .nbib Format: NLM
Synthetic polyphosphate inhibits endogenous coagulation and platelet aggregation .

Biomedical reports

Yang X, Wan M, Liang T, Peng M, Chen F.
PMID: 28123708
Biomed Rep. 2017 Jan;6(1):57-62. doi: 10.3892/br.2016.816. Epub 2016 Nov 23.

Platelet-derived polyphosphate has previously been indicated to induce coagulation. However, industrially synthesized polyphosphate has been found to have different effects from those of the platelet-derived form. The present study investigated whether synthetic sodium polyphosphate inhibits coagulation using routine coagulation...

Cite
Yang X, Wan M, Liang T, et al. Synthetic polyphosphate inhibits endogenous coagulation and platelet aggregation . Biomed Rep. 2016;6(1):57-62doi: 10.3892/br.2016.816.
Yang, X., Wan, M., Liang, T., Peng, M., & Chen, F. (2017). Synthetic polyphosphate inhibits endogenous coagulation and platelet aggregation . Biomedical reports, 6(1), 57-62. https://doi.org/10.3892/br.2016.816
Yang, Xiaoyang, et al. "Synthetic polyphosphate inhibits endogenous coagulation and platelet aggregation ." Biomedical reports vol. 6,1 (2017): 57-62. doi: https://doi.org/10.3892/br.2016.816
Yang X, Wan M, Liang T, Peng M, Chen F. Synthetic polyphosphate inhibits endogenous coagulation and platelet aggregation . Biomed Rep. 2017 Jan;6(1):57-62. doi: 10.3892/br.2016.816. Epub 2016 Nov 23. PMID: 28123708; PMCID: PMC5244767.
Copy Download .nbib Format: NLM
Redeeming ristocetin.

Blood

Sadler JE.
PMID: 20634385
Blood. 2010 Jul 15;116(2):155-6. doi: 10.1182/blood-2010-04-276394.

No abstract available.

Cite
Sadler JE. Redeeming ristocetin. Blood. 2010;116(2):155-6doi: 10.1182/blood-2010-04-276394.
Sadler, J. E. (2010). Redeeming ristocetin. Blood, 116(2), 155-6. https://doi.org/10.1182/blood-2010-04-276394
Sadler, J Evan. "Redeeming ristocetin." Blood vol. 116,2 (2010): 155-6. doi: https://doi.org/10.1182/blood-2010-04-276394
Sadler JE. Redeeming ristocetin. Blood. 2010 Jul 15;116(2):155-6. doi: 10.1182/blood-2010-04-276394. PMID: 20634385.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 123 entries